Torrent Pharmaceuticals Ltd has entered into a strategic alliance with Boehringer Ingelheim India Private Limited (BI India) to co-market Cospiaq (Empagliflozin), Cospiaq MetTM (Empagliflozin+ Metformin) and Xilingio (Empagliflozin+ Linagliptin) in India.
source https://www.pharmatutor.org/pharma-news/2022/torrent-pharma-inks-with-boehringer-ingelheim-to-market-anti-diabetics
No comments:
Post a Comment